New study aims to track dangerous infections in kids with sickle cell disease
NCT ID NCT07639008
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will look at medical records of 350 children with sickle cell disease in France who had serious bacterial infections between 2020 and 2025. The goal is to find out which bacteria are causing these infections today, especially with new vaccines available. The results could help improve prevention and treatment for these children.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better understand which bacteria cause serious infections in children with sickle cell disease, leading to improved vaccines and prevention plans.
- What could go wrong
- This is an observational study that only looks at past data, so it cannot test new treatments or prove what works best. The findings may not apply to children outside France.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INVASIVE BACTERIAL INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CH Gonesse
Gonesse, France
-
CH Rambouillet
Rambouillet, France
-
CH Rives de Seine, Site de Neuilly-sur-Seine
Neuilly-sur-Seine, France
-
CH Saint Denis, Hôpital Delafontaine
Saint-Denis, France
-
CH Sud Francilien
Corbeil-Essonnes, France
-
CH du Sud Seine et Marne
Fontainebleau, France
-
CHI Créteil
Créteil, France
-
CHI Poissy
Poissy, France
-
CHI Robert Ballanger
Aulnay-sous-Bois, France
-
CHU Lenval
Nice, France
-
CHU Nantes
Nantes, France
-
GH Sud Ile-de-france
Melun, France
-
GHEF, Site de Marne-la-Vallée
Jossigny, France
-
GHEF, Site de Meaux
Meaux, France
-
GHI Le Raincy-Montfermeil
Montfermeil, France
-
GHT Yvelines Nord
Mantes-la-Jolie, France
-
Hôpital Ambroise Paré
Boulogne-Billancourt, France
-
Hôpital André Mignot
Versailles, France
-
Hôpital Antoine Béclère
Clamart, France
-
Hôpital Bicêtre
Le Kremlin-Bicêtre, France
-
Hôpital Intercommunal Villeneuve-St-Georges
Villeneuve-Saint-Georges, France
-
Hôpital Jean Verdier
Bondy, France
-
Hôpital NOVO
Cergy-Pontoise, France
-
Hôpital Necker
Paris, France
-
Hôpital Nord, AP-HM
Marseille, France
-
Hôpital Paris-Saclay
Orsay, France
-
Hôpital Pellegrin - Hôpital des Enfants
Bordeaux, France
-
Hôpital Robert Debré
Paris, France
-
Hôpital Saint Camille
Bry-sur-Marne, France
-
Hôpital Trousseau
Paris, France
-
Hôpital Victor Dupouy (CH Argenteuil)
Argenteuil, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can gene therapy free sickle cell patients from painful crises?
- Simple breathing device may speed recovery from a deadly sickle cell complication
- Could ketamine beat opioids for sickle cell pain in kids?
- Major study to decide: transplant or medication for kids with sickle cell?
- Could a simple seed ease sickle cell pain? new study hopes to find out
- ER wait after admission costs millions, study finds